Details for 2018773692
Up to date per 01.04.2026
Actions
Details for 2018773692
Granted/Registered
European Patent
08.07.2020 A
17.05.2023 B1
28.08.2017
US
201762550983 P
25.01.2018
US
201862621730 P
A61K 9/00 20060101AFI20190308BHEP
Owner
TLC Biopharmaceuticals, Inc.611 Gateway Blvd., Suite 830 South San Francisco CA 94080US
Taiwan Liposome Company, Ltd.11F.-1, No.3, Yuanqu Street Nangang District Taipei City 11503TW
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
HONG, Keelung South San Francisco, CA 94080US
KAO, Hao-Wen11F-1 No. 3 Yuanqu Street Nangang District Taipei City 11503TW
LIN, Yi-Yu11F-1 No. 3 Yuanqu Street Nangang District Taipei City 11503TW
GUO, Luke, S.s. South San Francisco, CA 94080US
Information about Fees